| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Dabigatran | FAERS: 12 | US FAERS | |
| 2 | Lenalidomide | FAERS: 2 | US FAERS | |
| 3 | 2-(3-(4-ethoxybenzyl)-4-chlorophenyl)-6-hydroxymethyltetrahydro-2H-pyran-3,4,5-triol | FAERS: 1 | US FAERS | |
| 4 | 4-[(1R)-2-[6-[2-[(2,6-Dichlorophenyl)methoxy]ethoxy]hexylamino]-1-hydroxyethyl]-2-(hydroxymethyl)phenol;[(6S,8S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-17-(fluoromethylsulfanylcarbonyl)-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] furan-2-carboxylate;diphenyl-[1-(2-phenylmethoxyethyl)-1-azoniabicyclo[2.2.2]octan-4-yl]methanol | FAERS: 1 | US FAERS | |
| 5 | 4-hydroxybutyric acid | FAERS: 1 | US FAERS | |
| 6 | Albuterol | FAERS: 1 | US FAERS | |
| 7 | Ergoloid Mesylates | FAERS: 1 | US FAERS | |
| 8 | LCZ 696 | FAERS: 1 | US FAERS | |
| 9 | Metformin | FAERS: 1 | US FAERS | |
| 10 | Zoledronic Acid | FAERS: 1 | US FAERS | |
| 11 | elbasvir-grazoprevir drug combination | FAERS: 1 | US FAERS | |
| 12 | macitentan | FAERS: 1 | US FAERS | |
| 13 | obeticholic acid | FAERS: 1 | US FAERS | |
| 14 | pirfenidone | FAERS: 1 | US FAERS | |
| 15 | pomalidomide | FAERS: 1 | US FAERS | |
| 16 | regorafenib | FAERS: 1 | US FAERS |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120241
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.